Pleomorphic liposarcoma

2 trials 2 recruiting MedDRA PT
2 Registered trials
2 Recruiting
2 Unique sponsors
5 Unique IMPs
1 Commercial trials
Drug classes (ATC)
L Oncology (ATC L) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Kinase inhibitor 1 substance
Vinca alkaloid 1 substance
Phase III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

2 trials
  • Intensity Therapeutics Inc. Commercial
    ERIBULIN; PAZOPANIB; TRABECTEDIN; VINBLASTINE SULFATE, CISPLATIN
    2024-512423-36-00 5 countries 2024 n=118
    Recruiting
  • Universitaet Muenster Academic
    TTF-NGR
    2024-516392-33-00 1 country 2021 n=126
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Intensity Therapeutics Inc. Commercial 1 Phase III 1
Universitaet Muenster Academic 1 Phase III 1
New trials by year
2021
1
2024
1
← All indication landscapes